Based in Sweden, Gesynta is a startup founded in 2025. Brouky records 1 investor associated with the company.
Gesynta Pharma develops pharmaceutical treatments for inflammation, focusing on endometriosis and chronic inflammatory pain through the inhibition of the mPGES-1 enzyme.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.